Navelbine and Cholestasis - a phase IV clinical study of FDA data

Summary:

Cholestasis is reported as a side effect among people who take Navelbine (vinorelbine tartrate), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Bactrim, and have Pain.

The phase IV clinical study analyzes which people have Cholestasis when taking Navelbine. It is created by eHealthMe based on reports of 8,697 people who have side effects when taking Navelbine from the FDA, and is updated regularly.

What is Navelbine?

Navelbine has active ingredients of vinorelbine tartrate. It is often used in breast cancer. eHealthMe is studying from 8,750 Navelbine users. Check the latest studies of Navelbine.

What is Cholestasis?

Cholestasis (a condition where bile cannot flow from the liver to the duodenum) is found to be associated with 1,034 drugs and 1,808 conditions by eHealthMe. Check the latest studies of Cholestasis.

On Jul, 11, 2026

8,697 people reported to have side effects when taking Navelbine.
Among them, 25 people (0.29%) have Cholestasis.

Among these 25 people:

How long have people been on Navelbine when they have Cholestasis? *

What is the gender of people who have Cholestasis when taking Navelbine? *

female: 72.73 %
male: 27.27 %

What is the age of people who have Cholestasis when taking Navelbine? *

What are other drugs people take besides Navelbine? *

Bactrim: 7 people, 28.00%
Votrient: 5 people, 20.00%
Etoposide: 4 people, 16.00%
Movicol: 4 people, 16.00%
Gemzar: 4 people, 16.00%
Fungizone: 3 people, 12.00%
Vitamin C: 3 people, 12.00%
Lovenox: 3 people, 12.00%
Sodium Bicarbonate In Plastic Container: 3 people, 12.00%
Prednisone: 3 people, 12.00%

What are other side effects people have besides Cholestasis? *

Hepatocellular Injury (liver injury): 6 people, 24.00%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 20.00%
Fever: 5 people, 20.00%
Rash Papular (redness with papule): 4 people, 16.00%
Muscle Aches (muscle pain): 4 people, 16.00%
Pain In Extremity: 3 people, 12.00%
Cough: 3 people, 12.00%
Chest Pain: 3 people, 12.00%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 3 people, 12.00%
Pneumonia: 3 people, 12.00%

What are the existing conditions these people have? *

Tonsil Cancer: 5 people, 20.00%
Pain: 5 people, 20.00%
Constipation: 4 people, 16.00%
Non-Small Cell Lung Cancer Metastatic (type of epithelial lung cancer spreads to other parts): 3 people, 12.00%
Lung Cancer - Non-Small Cell (lung cancer): 2 people, 8.00%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 8.00%
Breast Cancer Metastatic: 2 people, 8.00%
Neoplasm Malignant (cancer tumour): 2 people, 8.00%
Nasal Sinus Cancer (cancer of hollow cavity behind nose): 1 person, 4.00%
Stress And Anxiety: 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Navelbine and have Cholestasis?

- Check whether Cholestasis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Navelbine:

Navelbine (8,750 reports)

Cholestasis treatments and more:

Cholestasis (23,731 reports)

Browse all side effects of Navelbine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cholestasis:

Cholestasis (1,034 drugs)

Browse all the conditions that are associated with Cholestasis:

Cholestasis (1,808 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on vinorelbine tartrate (the active ingredients of Navelbine) and Navelbine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.